Authors: VANDEVELDE V CRABBE R VANPEER A WOESTENBORGHS R VANOSSELAER N HANTSON L HEYKANTS J

Citation: V. Vandevelde et al., PHARMACOKINETICS OF LUBELUZOLE (PROSYNAP) AFTER SINGLE INTRAVENOUS DOSES IN HEALTHY-SUBJECTS, International journal of clinical pharmacology and therapeutics, 36(9), 1998, pp. 490-493

Authors: DEKEYSER J VANDEVELDE V SCHELLENS RLLA HANTSON L TRITSMANS L GHEUENS J VANPEER A WOESTENBORGHS R FRANKE CL VANGORP J

Citation: J. Dekeyser et al., SAFETY AND PHARMACOKINETICS OF THE NEUROPROTECTIVE DRUG LUBELUZOLE INPATIENTS WITH ISCHEMIC STROKE, Clinical therapeutics, 19(6), 1997, pp. 1340-1351

Authors: PIERARDFRANCHIMONT G DEDONCKER P VANDEVELDE V JACQMIN P ARRESE JE PIERARD GE

Citation: G. Pierardfranchimont et al., PARADOXICAL RESPONSE TO ITRACONAZOLE TREATMENT IN A PATIENT WITH ONYCHOMYCOSIS CAUSED BY MICROSPORUM-GYPSEUM, Annales de la Societe belge de medecine tropicale, 75(3), 1995, pp. 211-217

Authors: HEYKANTS J VANPEER A VANDEVELDE V SNOECK E MEULDERMANS W WOESTENBORGHS R

Citation: J. Heykants et al., THE PHARMACOKINETIC PROPERTIES OF TOPICAL LEVOCABASTINE - A REVIEW, Clinical pharmacokinetics, 29(4), 1995, pp. 221-230

Authors: DUCHARME MP SLAUGHTER RL WARBASSE LH CHANDRASEKAR PH VANDEVELDE V MANNENS G EDWARDS DJ

Citation: Mp. Ducharme et al., ITRACONAZOLE AND HYDROXYITRACONAZOLE SERUM CONCENTRATIONS ARE REDUCEDMORE THAN TENFOLD BY PHENYTOIN, Clinical pharmacology and therapeutics, 58(6), 1995, pp. 617-624